Content Type: Article

  • New York City’s COVID-19 Vaccine Mandate for Private Employers and Other Recent Developments

    New York City’s COVID-19 Vaccine Mandate for Private Employers and Other Recent Developments

    ARTICLE / CLIENT ALERT

    New York City’s COVID-19 Vaccine Mandate for Private Employers and Other Recent Developments

    December 21, 2021

    Read time: 7 min

    Key takeaways
    Overview

    Following Mayor Bill de Blasio’s announcement of a vaccine mandate for private-sector workers in New York City, the New York City Commissioner of Health and Mental Hygiene (“Commissioner”) issued an order dated Dec. 13, 2021 (“Order”). Employers in New York City are required by Dec. 27, 2021 to prohibit unvaccinated workers from entering their workplaces, with limited exceptions. The City subsequently posted FAQ Guidance and a flyer.

    Employers and Workers Subject to the Order

    The Order affects all “Covered Entities,” which are defined to include any non-governmental entity that employs one or more workers in New York City or operates a workplace in New York City. The Order does not apply to Covered Entities or individuals who are already subject to another order of the Commissioner, Board of Health, the Mayor or a state or federal entity that requires them to maintain proof of full vaccination, or to individuals who have been granted a reasonable accommodation under those requirements. Covered Entities or individuals, however, must comply with this Order if they are subject to federal requirements that are not in effect because of a court order. A “workplace” encompasses any location, including vehicles and co-working spaces, where work is performed in the presence of other workers or members of the public.

    Covered Entities must obtain proof of at least one dose of a COVID-19 vaccine from each of their workers by Dec. 27, 2021, regardless of where the workers live. “Workers” are defined as individuals who work in-person in New York City at a workplace, and include full and part-time employees, interns, volunteers, a Covered Entity’s contractors, and self-employed individuals or solo practitioners.

    The Order does not apply to:

    • Individuals who work from home and do not have in-person interactions with co-workers or members of the public;
    • An individual who only enters the workplace for a quick or limited purpose[1];
    • A performing artist or athlete who does not need to be vaccinated under the Key to New York City program; and
    • Individuals who have been granted an accommodation.

    Compliance with the Order

    Covered Entities must verify their workers’ proof of vaccination by either:

    • Making a copy of each worker’s proof of vaccination or record of reasonable accommodation; or
    • Maintaining a record of each worker’s vaccination information, which record must state (i) the worker’s name, (ii) whether the worker is fully vaccinated,[2] and (iii) for a worker that submits proof of only the first dose of a two-dose vaccine, the date by which the worker must submit proof of the second dose, which must be no later than forty-five (45) days after proof of the first dose was submitted,[3] or (iv) for a worker that requests a reasonable accommodation, supporting records[4]; or
    • Checking and recording each worker’s proof of vaccination before the worker enters the workplace.

    With respect to contractors, Covered Entities may ask the contractor’s employer to confirm that the contractor is vaccinated and maintain a record of such request and confirmation instead of directly requesting proof of the contractor’s vaccination status.

    Workers may request a reasonable accommodation to be exempt from this Order’s requirements. Reasonable accommodations may be granted only for documented medical or religious reasons. Employers should consider each request on a case-by-case basis. For more information about reasonable accommodations, see the Equal Employment Opportunity Commission’s COVID-19 guidance.

    All records related to vaccination and reasonable accommodations must be kept confidential and stored separately from employees’ personnel files.

    Affirmation of Compliance

    Covered Entities must sign and post the Affirmation of Compliance in a conspicuous location by Dec. 27, 2021.[5] Covered Entities who refuse to comply with the Order will be subject to a $1,000 fine, and escalating penalties thereafter if violations persist.

    Other COVID-19 Mandates for New York City Employers

    Employers are also bound by New York State’s Determination on Indoor Masking (“Mask Mandate”). The Mask Mandate is currently in effect through Jan. 15, 2022, at which time it will be reevaluated. The Mandate requires masks to be worn in all indoor public places, defined as any indoor space that is not a private residence, including business and office spaces. The Mask Mandate, however, does not apply to indoor public places that require all individuals, including visitors, to provide proof of vaccination as a condition of entry to such place. Therefore, employers may avoid requiring masks in their workplace while complying with both the Order and Mask Mandate if they adopt a mandatory vaccination policy that requires all individuals, including visitors, entering their offices to show proof of vaccination as a condition of entry.

    The New York State Commissioner of Health has extended the designation of COVID-19 as a “highly contagious communicable disease” under the New York State Health and Essential Rights Act (“HERO Act”) until at least Jan. 15, 2022. Therefore, employers must continue to comply with their airborne infectious disease exposure prevention plans. More information about the HERO Act can be found in a previous SRZ Alert.

    Finally, private employers should note that a new amendment to the Earned Safe and Sick Time Act requires that employers provide employees with up to four (4) hours of paid leave for each time their child receives a dose of a COVID-19 vaccine.

    Please contact Mark E. Brossman, Ronald E. Richman, Max Garfield, Scott A. Gold, Donna K. Lazarus or Abdulrahman Alwattar if you have any questions about these orders.


    [1] Examples of a quick or limited purpose include using the bathroom, making a delivery, and clocking in to receive an assignment before leaving to begin the assignment.

    [2] A worker is “fully vaccinated” once at least two weeks have passed after the worker received (i) a second dose of a two-dose vaccine series, such as the Pfizer or Moderna vaccines; or (ii) a single dose of a vaccine that only requires one-dose, such as the Johnson & Johnson vaccine.

    [3] Workers who fail to provide proof of a second dose within forty-five (45) days must be prohibited from the workplace until they can provide proof of their second dose. Whether workers who do not provide proof of vaccination are fired, disciplined, or allowed to work remotely is at the discretion of the Covered Entity.

    [4] Covered Entities may allow workers to enter the workplace while their reasonable accommodation request is pending. Covered Entities may use the following checklist, which the City will regard as an appropriate handling of a reasonable accommodation request.

    [5] Covered Entities that have already posted a notice pursuant to the Key to New York City program do not need to post this Affirmation. Additionally, Covered Entities that do not have a fixed workplace or work in a vehicle may instead keep their proof of vaccination with them at all times.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Mark E. Brossman

    Partner

    New York – 919 Third Avenue

    Ronald E. Richman

    Partner

    New York – 919 Third Avenue

    Max Garfield

    Partner

    New York – 919 Third Avenue

    Donna K. Lazarus

    Partner

    New York – 919 Third Avenue

    Abdulrahman Alwattar

    Associate

    New York – 919 Third Avenue

    More insights

  • Federal Vaccine Mandates Are Back in Play—For Now

    Federal Vaccine Mandates Are Back in Play—For Now

    ARTICLE / CLIENT ALERT

    Federal Vaccine Mandates Are Back in Play—For Now

    December 20, 2021

    Read time: 6 min

    Key takeaways
    Overview

    This article was updated on December 29, 2021. 

    The courts continue to move the vaccine mandate goalposts on employers as dozens of legal challenges work their way through the courts. The latest developments are major game changers for employers. As of the publishing of this On the Subject, the US Occupational Safety and Health Administration (OSHA) Emergency Temporary Standard (ETS) vaccine-or-test rule is enforceable nationwide, and the US Centers for Medicare & Medicaid Services (CMS) Interim Final Rule (IFR) mandating vaccination, subject to exemptions, is enforceable in 25 states.

    In depth

    BACKGROUND

    As we previously reported, in September 2021, US President Joe Biden announced a three-part federal vaccine mandate for large employers, certain healthcare providers and federal contractors. In furtherance of that announcement, OSHA issued its ETS requiring large employers with 100+ employees to implement a vaccine-or-testing policy (or a vaccine mandate, if preferred); CMS issued an IFR requiring vaccination, subject to exemptions; and the federal government issued its guidance requiring covered federal contractors to mandate vaccination, as well.

    Litigation ensued in multiple venues as to all three federal vaccine mandates, and courts issued various stays of enforcement as to each mandate, effectively staying enforcement on any federal vaccine mandate nationwide.

    However, on December 15, 2021, the US Court of Appeals for the Fifth Circuit lifted the CMS IFR stay as to 25 states, and on December 17, 2021, the US Court of Appeals for the Sixth Circuit dissolved the OSHA ETS stay nationwide.

    SUMMARY OF VACCINE MANDATE STATE-OF-PLAY

    High-level, the following is a summary of the enforceability and deadlines on each of the three federal vaccine requirements:

    • The OSHA ETS stay of enforcement has been lifted nationwide. On December 17, 2021, OSHA issued a statement confirming that it plans to enforce its ETS, but the agency will have a grace period for compliance, as follows:
      • Immediately, employers must start taking good faith steps to come into compliance with the standard.
      • January 10, 2022, is the new deadline to have a written policy, require masking for unvaccinated employees and provide PTO for employees to get vaccinated.
      • February 9, 2022, is the new deadline to require unvaccinated employees to begin testing weekly for COVID-19.
    • The CMS IFR stay of enforcement has been lifted as to 25 states. CMS announced that it plans to begin enforcement in these states, with the deadline for first vaccine doses now set at January 27, 2022; and the deadline for second vaccine doses now February 28, 2022. More information on CMS’ enforcement efforts here.
    • The federal contractor vaccine mandate is currently under a nationwide stay of enforcement. No enforcement is permitted at this time.

    Additional details regarding each vaccine mandate are below. The legal landscape remains fluid on these rules, and impending Supreme Court of the United States appeals may change the state of play further.

    VACCINE MANDATE STATE-OF-PLAY: IN DETAIL

    OSHA ETS (vax-or-test mandate for large employers): 

    • What is the latest development? The OSHA ETS nationwide stay was dissolved by the Sixth Circuit on December 17, 2021.
      • Previously, the Fifth Circuit originally issued a nationwide stay of enforcement on this vax-or-test rule pending resolution of the case on the merits; however, as is the procedure when there are multiple similar challenges in various circuit courts, the case was then consolidated with other similar challenges and transferred to the Sixth Circuit for further review.
    • What does this mean? The dissolution of the stay means that OSHA could begin enforcement of the ETS nationwide immediately. OSHA issued a statement confirming that it plans to enforce its ETS, but the agency will permit a grace period for compliance.
      • Immediately, employers must start taking good faith steps to come into compliance with the standard.
      • January 10, 2022, is the new deadline to have a written policy, require masking for unvaccinated employees and provide PTO for employees to get vaccinated.
      • February 9, 2022, is the new deadline to require unvaccinated employees to begin testing weekly for COVID-19.
    • What’s next? This decision is appealable and will likely be appealed by the ETS challengers, ultimately seeking review from the Supreme Court.

    CMS IFR (vaccine mandate for specified CMS-regulated provider/supplier types):

    • What is the latest development? The CMS IFR nationwide stay was lifted as to 25 states this week by the Fifth Circuit. The other 25 states remain under an enforcement stay. (The list of states with or without a stay is in the below chart; however, the list remains fluid day-to-day as courts issue piecemeal orders.)
      • Previously, the CMS IFR was originally subject to several piecemeal stays of enforcement issued by multiple courts. The Fifth Circuit order narrowed one of those courts’ broad stays, limiting it only to the plaintiff states in the litigation.
    • What does this mean? CMS has viewed the partial dissolution of the stay to permit the agency to  begin enforcement of its rule in the 25 states that do not currently have a stay in place. For more information, see our previous client alert, “CMS issues detailed guidance to surveyors on assessing compliance with omnibus COVID-19 healthcare staff vaccination mandate.”
    • What’s next? Two big-picture items to look out for:
      • More piecemeal stays may be in our future. When the Fifth Circuit partially lifted the stay on Wednesday, December 15, it was lifted as to 26 states including Texas, and a Texas court quickly implemented a statewide stay. We expect other states may follow suit in the days to come, so the state list remains fluid.
      • On the other side, CMS has asked the Supreme Court to lift the stay as to the remaining stayed states, and the Supreme Court has set a briefing schedule that has briefs due through December 30, so we do not expect a ruling on this from the Supreme Court until early 2022.
    CMS IFR Stay on Enforcement Remains in Place – CMS Cannot Enforce IFR Here: CMS IFR Stay is Lifted – CMS Could Enforce IFR Here:
    Alabama California
    Alaska Colorado
    Arizona Connecticut
    Arkansas Delaware
    Georgia Florida
    Idaho Hawaii
    Indiana Illinois
    Iowa Maine
    Kansas Maryland
    Kentucky Massachusetts
    Louisiana Michigan
    Mississippi Minnesota
    Missouri Nevada
    Montana New Jersey
    Nebraska New Mexico
    New Hampshire New York
    North Dakota North Carolina
    Ohio Oregon
    Oklahoma Pennsylvania
    South Carolina Rhode Island
    South Dakota Tennessee
    Texas Vermont
    Utah Virginia
    West Virginia Washington
    Wyoming Wisconsin

    Federal Contractor Guidance (vaccine mandate for covered federal contractors and subcontractors):

    • What is the latest development? The federal contractor rule remains stayed nationwide pursuant to a court order issued December 7, 2021.
    • What does this mean? At this time, the federal government cannot enforce their contractor vaccine mandates.
    • What’s next? Expect legal challenges to this stay by the federal government.

    We are here to help. Please contact the authors of this article or your McDermott lawyer for more information.

    Authors

    Abigail M. Kagan

    Partner

    New York – One Vanderbilt Avenue

    Sandra M. DiVarco

    Partner

    Chicago

    More insights

  • FTC Announces 2022 Reviews of Key Guides and Rules

    FTC Announces 2022 Reviews of Key Guides and Rules

    ARTICLE / CLIENT ALERT

    FTC Announces 2022 Reviews of Key Guides and Rules

    December 20, 2021

    Read time: 5 min

    Key takeaways
    Overview

    The US Federal Trade Commission (FTC) has announced a series of new reviews scheduled for 2022 regarding key FTC guides and rules. Consumer-facing businesses should pay close attention to these reviews. While FTC reviews are periodic and can be routine, they can also result in fundamental changes to how the FTC approaches enforcement of key issues. Review periods can also provide an opportunity for impacted businesses to submit public comment and opinion to the FTC for consideration.

    In depth

    The FTC’s ongoing and upcoming reviews were highlighted in the Biden administration’s recently released Fall 2021 Unified Agenda of Regulatory and Deregulatory Actions; this publication highlights federal agencies’ regulatory action plans for the coming year. The FTC’s Statement on Regulatory Priorities announced that the agency will undertake a thorough review and examination of the guidance provided in, and the enforcement of, the following key guides and rules:

    • Guides Against Deceptive Pricing: These Guides address types of pricing representations, such as marketer representations that a price is a “sale” or “discount,” comparisons to others’ prices or manufacturers’ retail prices and representations about special prices based on the purchase of other goods or services (e.g., “buy-one-get-one” offers).
    • Guide Concerning Use of the Word ‘Free’ and Similar Representations: This Guide sets forth requirements when using the promotional device of offering “free” merchandise or services. When making such offers, the Guide requires all terms and conditions be set forth clearly and conspicuously at the outset of the offer to avoid any reasonable probability that the terms might be misunderstood.
    • Guides for the Use of Environmental Claims (Green Guides): The Green Guides provide the general principles applying to all environmental marketing claims; how consumers will likely interpret certain claims and how marketers can substantiate such claims; and how marketers can qualify such claims to prevent deception of consumers.
    • Business Opportunity Rule: This Rule requires business opportunity sellers to give prospective buyers particular information to aid in their evaluation of a business opportunity. The FTC intends to initiate review of this Rule by late 2021.
    • Amplifier Rule: This Rule creates uniform test standards and disclosures for consumers to make more meaningful comparisons of amplifier equipment performance attributes. The FTC plans to submit a recommendation for further Commission action on review of this Rule by February 2022.

    In addition to those newly announced reviews, the report also discussed the following ongoing FTC reviews:

    • Children’s Online Privacy Protection Rule (COPPA): COPPA imposes requirements on operators of websites or online services directed to children under age 13 as well as on operators of websites or online services that have actual knowledge that they are collecting personal information online from a child under age 13. FTC staff is continuing to analyze and review the public comments; however, the period for comment on COPPA ended in late 2019.
    • Guides Concerning the Use of Endorsements and Testimonials in Advertising (Endorsement Guides): These guidelines are designed to help businesses and other advertisers of TV, print, radio, blogs, word-of-mouth marketing, etc., and they ensure they meet truthful and not misleading standards. Although the period for public comment on the Guides ended in 2020, FTC staff is still reviewing these comments.
    • Guides for Select Leather and Imitation Leather Products (Leather Guides): The Leather Guides address misrepresentations about the composition and characteristics of certain leather and imitation leather products. The Guides mandate disclosure of non-leather content for material that appears to be, but is not, leather. FTC staff intends to submit a recommendation for further Commission action by the end of 2021.
    • Rule Concerning the Use of Prenotification Negative Option Plans (Negative Option Rule): The Negative Option Rule helps consumers avoid recurring payments for products or services they did not intend to order and permits them to cancel such payments without unwarranted obstacles. In 2019, the FTC issued an Advance Notice of Proposed Rulemaking regarding the Rule, but the agency noted its next expected action is “undetermined” as it “stud[ies] various options.”
    • Telemarketing Sales Rule: This Rule requires telemarketers to make specific disclosures of material information, prohibits misrepresentations, sets limits on the times telemarketers may call consumers, prohibits calls to consumers who have asked not to be called again, and sets payment restrictions for the sale of certain goods and services. The FTC’s review of this Rule began in 2014; the agency’s staff stated it intended to make a recommendation to the Commission in November 2021.

    While President Biden’s Executive Order on Antitrust garnered a lot of headlines, the agenda and recent announcements by the FTC indicate that 2022 will see an equally aggressive pursuit of consumer protection issues.

    Authors
    More insights

  • CFPB Authorizes Debt Collectors to Use Social Media, Text and Email

    CFPB Authorizes Debt Collectors to Use Social Media, Text and Email

    ARTICLE / CLIENT ALERT

    CFPB Authorizes Debt Collectors to Use Social Media, Text and Email

    December 20, 2021

    Read time: 4 min

    Key takeaways
    Overview

    A new rule adopted in the last administration has now gone into effect.[1] The Debt Collection Rule, which implements the Fair Debt Collection Practices Act, permits debt collectors to contact consumers “through any medium,” including on social media, by text message and email, in addition to phone calls and letters.[2]

    Although the new administration resulted in a new CFPB Director, the agency has stated that it plans to keep the new rule for now, opting to monitor its effects and only then pursue new rulemaking, rather than trying to withdraw or delay the rule before it went into effect.[3]

    Under the Debt Collection Rule, a debt collector can contact a consumer by email, text message or social media so long as:

    • Any social media communication is a private direct message that other users on the platform cannot see;
    • Any connection request on social media clearly identifies the person as a debt collector; and
    • They provide a simple method for the consumer to opt-out of further communications.[4]

    While consumers will very likely notice these changes as the texts, emails and direct messages roll in, this is unlikely to tamper the CFPB’s interest in or ability to defend consumers with outstanding debts. The CFPB has broad authority to enforce against unfair, deceptive and abusive acts or practices (“UDAAPs”).[5] Additionally, the FTC’s Telemarketing Sales Rule reaches debt collectors as well as their service providers, including payment processors, who facilitate practices the regulators deem improper.[6] As an FTC Commissioner, now CFPB Director, Rohit Chopra was particularly vocal about reining in debt collection practices through enforcement, including joint enforcement where the FTC and CFPB work together.[7] Director Chopra has also been vigilant against attempts to revive expired debts.[8]

    Payment processors and other businesses that are involved in debt collection should carefully review their policies and procedures and their clients’ practices to promote compliance with this new rule and with the enforcement that will ensure debt collectors do not take undue advantage of this new medium.

    Authored by Donald J. Mosher, Kara A. Kuchar, Douglas I. Koff and Noah N. Gillespie.

    If you have any questions concerning this Alert, please contact your attorney at Schulte Roth & Zabel or one of the authors.


    [1] “Can a debt collector contact me through social media?” CFPB (Nov. 30, 2021), available here.

    [2] 12 C.F.R. § 1006.2(d) & cmt. 1.

    [3] Michelle Singletary, “New rule will allow debt collectors to track you down on social media,” The Washington Post (Nov. 30, 2021), available here.

    [4] CFPB, supra; 12 C.F.R. § 1006.6.

    [5] E.g., “CFPB Policy Rescission Stakes Out Broad Enforcement Authority,” SRZ Client Alert (March 22, 2021), available here.

    [6] Telemarketing Sales Rule, 16 C.F.R. part 310.

    [7] E.g., Statement of Commissioner Rohit Chopra, In the Matter of Midwest Recovery Systems, File No. 1923042 (Nov. 25, 2020) (dissenting).

    [8] Singletary, supra.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Donald J. Mosher

    Partner

    New York – 919 Third Avenue

    Douglas I. Koff

    Partner

    New York – 919 Third Avenue

    More insights

  • SEC Sets the Table for Stricter Rule 10b5-1 Insider Trading Plans and Enhanced Disclosures for Company Repurchases

    SEC Sets the Table for Stricter Rule 10b5-1 Insider Trading Plans and Enhanced Disclosures for Company Repurchases

    ARTICLE / CLIENT ALERT

    SEC Sets the Table for Stricter Rule 10b5-1 Insider Trading Plans and Enhanced Disclosures for Company Repurchases

    December 17, 2021

    Read time: 6 min

    Key takeaways
    Overview

    Earlier this week, the US Securities and Exchange Commission (SEC) proposed amendments to Exchange Act Rule 10b5-1 that would impose new restrictions and disclosure requirements for (1) trading plans that afford executives and other insiders the “good faith” affirmative defense against allegations of insider trading and (2) enhanced company stock repurchases. These actions were not unexpected. In June 2021, SEC Chair Gary Gensler said it was time to “freshen up” Rule 10b5-1 and directed SEC staff to recommend restrictions on the use of Rule 10b5-1 trading plans, including a cooling off period before trading could commence under a plan. Similarly, Chair Gensler explained the rationale for increased disclosure rules with respect to stock purchase plans, “Share buybacks have become a significant component of how public issuers return capital to shareholders…we can lessen the information asymmetries between issuers and investors through enhanced timeliness and granularity of disclosures that today’s proposal would provide.”

    In depth

    PROPOSED CHANGES TO RULE 10B5-1

    Both Chair Gensler and former SEC Chair Jay Clayton have raised concerns and cited data indicating that the lack of adequate disclosures and mandatory waiting periods have allowed executives to profit on inside information. The proposed amendments to Rule 10b5-1 to add restrictions and enhance disclosure include the following:1

    • A 120-day cooling off period before any trading by corporate officers and directors can commence under a Rule 10b5-1 plan after its adoption; the same 120 days restriction would also apply to the adoption of a modified trading arrangement. Issuer Rule 10b5-1 plans would be subject to a 30-day cooling off period.
    • Disallowing the affirmative defense of Rule 10b5-1 when utilizing multiple overlapping Rule 10b5-1 trading plans for open market trades in the same class of securities.
    • Rule 10b5-1 trading plans implemented for a single trade are limited to one plan per 12-month period.
    • Officers and directors must certify to the issuer that they are not aware of material nonpublic information when adopting new or modified Rule 10b5-1 plans.

    In terms of “enhanced disclosures,” the proposed rules include the following requirements:

    • Issuers must disclose in their quarterly reports the adoption and termination of all Rule 10b-5-1 trading plans by officers, directors and the issuer and the duration and aggregate number of shares that may be bought or sold under such plans.
    • Issuers must disclose in their annual reports their insider trading policies and procedures if they have adopted such policies and procedures. If they have not adopted insider trading policies and procedures, they must disclose why not.
    • Section 16 officers and directors must disclose whether a reported transaction was made pursuant to a Rule 10b5-1 trading plan by checking a box on Forms 4 and 5.
    • Issuers must disclose in their annual reports their option grant policies and practices and provide tabular disclosure showing grants made within 14 days of the release of material nonpublic information and the market price of the underlying securities on the trading day before and after the release of such information.

    All five commissioners approved the issuance of the proposed rules, which ratchets up the likelihood that the proposed amendments will be adopted in similar form after the comment period. The public will have an opportunity to submit comments within 45 days after the proposed rules are published in the Federal Register.

    PROPOSED CHANGES WITH RESPECT TO ISSUE REPURCHASE PROGRAMS  

    The new proposed rules with respect to issuer repurchase programs will provide for enhanced disclosure regarding issuer  repurchases.2 Current SEC rules require issuers to disclose repurchase information in their quarterly and annual reports, but the information is limited to disclosing the amount of shares purchased, the price paid and the maximum number of shares that may yet be purchased under approved repurchase plans.3 The proposed rules increase the amount of information disclosed on share repurchases, as well as the frequency of such disclosure. The SEC believes this enhanced disclosure will permit investors to better understand the impact of issuer share repurchases on the issuer’s stock price, the issuer’s motivation for share repurchases and any relationship between share repurchases and executive compensation and stock sales.

    Under the proposed rules:

    • Issuers would be required to file a new Form SR with the SEC one business day after execution of a repurchase order, disclosing the stock repurchases.
    • The required information to be disclosed in quarterly and annual reports would be more comprehensive to include:
      • The objective or rationale for its share repurchases and process or criteria used to determine the amount of repurchases.
      • Any policies and procedures relating to purchases and sales of the issuer’s securities by its officers and directors during a repurchase program, including any restriction on such transactions.
      • Whether the issuers made their repurchases pursuant to a plan that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c), and if so, the date that the plan was adopted or terminated.
      • Whether purchases were made in reliance on the Rule 10b-18 non-exclusive safe harbor.

    The proposed rules also require that the issuer tag in XBRL the new Form SR and new quarterly and annual disclosures to make the disclosures more readily available and easily accessible to investors, market participants and others for aggregation, comparison, filtering and other analysis.

    The public will have an opportunity to submit comments within 45 days after the proposed stock repurchase disclosure rules are published in the Federal Register.

    The McDermott Corporate and White-Collar teams recommend that companies begin planning now by adjusting insider trading plans, repurchase programs, updating policies and disclosures and educating executives and board members about the expected changes. The Firm’s Corporate and White-Collar Practice Groups stand ready to assist in that regard and as counsel to those considering submitting comments on the proposed rules.


    1 See SEC’s Rule 10b5-1 and Insider Trading, Release No. 33-11013; 34-93782; File No. S7-20-21. https://www.sec.gov/rules/proposed/2021/33-11013.pdf.
    2 See SEC’s Share Repurchase Disclosure Modernization, Release Nos. 34-93783; IC-34440; File No. S7-21-21. https://www.sec.gov/rules/proposed/2021/34-93783.pdf.
    3 See Regulation S-K Rule 703.

    Authors

    Eric Orsic

    Partner

    Chicago

    Heidi J. Steele

    Partner

    Chicago

    More insights

  • Log4j: Questions and Considerations for Companies and Their Vendors

    Log4j: Questions and Considerations for Companies and Their Vendors

    ARTICLE / CLIENT ALERT

    Log4j: Questions and Considerations for Companies and Their Vendors

    December 17, 2021

    Read time: 5 min

    Key takeaways
    Overview

    As highlighted in our December 10, 2021, article, the Apache Log4j vulnerability is garnering significant attention throughout the public and private sectors. There are reportedly upwards of 100 million devices and servers affected by the security flaw. The software has broad use in a variety of consumer and enterprise services, websites and applications, as well as in operational technology products. The exploit is said to be easy to mimic and install; there are apparently already online instructions and sample code enabling would-be malign actors, too.

    According to a recent statement from the Director of the Department of Homeland Security’s Cybersecurity and Infrastructure Security Agency (CISA), there has been “active, widespread exploitation” of the identified vulnerability. This is consistent with media reports that ransomware threat actors—as well as advanced persistent threat (APT) groups with links to the governments of Iran, Turkey, North Korea and China—are exploiting the flaw. CISA has deemed the vulnerability critical, directed all civilian federal agencies to “urgently patch or remediate” it and “signal[ed]” that non-federal partners follow suit.1 The FBI is requesting that Log4j victims report to its Internet Crime Complaint Center (IC3.gov) as much information as possible to assist the FBI and CISA in determining prioritization for outreach.

    In depth

    The situation continues to develop rapidly, with Apache issuing two additional Log4j-related Common Vulnerabilities and Exposures (CVE) disclosures and releasing two updates on December 13 and 17, 2021. Companies that updated Log4j to versions 2.15.0 and/or 2.16.0 will need to immediately implement version 2.17.0, as the prior versions are no longer deemed secure.

    Additionally, threat actors are developing new methods to evade the original mitigation techniques deployed at the network level. Companies are advised to continue monitoring the situation in the coming weeks and months as new patches are released—both for Log4j and applications that incorporate Log4j—and additional exploit signatures become available for web application firewalls (WAFs), intrusion prevention and detection systems (IPS/IDS) and endpoint protection software.

    The risk from Log4j is not limited to a company’s own systems and networks. Companies should look beyond their own environments to assess whether, and to what extent, their vendors and their vendors’ vendors are using the Apache Log4j library, prioritizing those vendors with access to company systems and data. The following are some initial considerations and issues that a company might explore with its vendors (and of itself if not already done):

    • Whether the vendor has conducted a vulnerability assessment to identify if they have potentially been impacted by Log4j (including the vendor’s systems and their software products or services, as well as those of their vendors);
    • Whether the vendor uses Log4j in any way in its systems or software products;
    • If the vendor uses Log4j, whether it has made the required patches and updates and/or completed other recommended remediation measures to address the vulnerability in their systems and software products;
    • If the vendor uses Log4j, a description of the controls it has implemented to mitigate additional risk posed by this vulnerability;
    • Whether the vendor is conducting daily (if not more frequently) searches of the regularly updated lists of known vulnerable vendors and applications (e.g., https://github.com/NCSC-NL/log4shell/tree/main/software) to identify whether the vendor uses any of those vulnerable vendors or applications;
    • Whether the vendor has discovered any indicators of compromise (IoCs) related to Log4j within their environment or the environment of their vendors; and
    • Whether the vendor has a point of contact who can answer additional questions.

    The questions above are intended to provide companies with considerations for itself and conversations with vendors, as well as to assist vendors with the inquires they are likely to receive. Unfortunately, the types of vendors a company should consider querying may be quite broad; these vendors may include a company’s cloud providers, software product providers, managed service providers, outsourcing vendors, and practically anyone with access to a company’s networks, systems or data. Seemingly small devices (e.g., IoT devices like network printers and cameras) may be in scope for this review.

    Companies also should consider engaging forensics experts to help track down and validate the answers to these questions and monitor their systems over the coming days, weeks and months as more becomes known about the pace and characteristics of this threat. Additional patching may be required for Log4j and applications that use this popular library as security researchers test the latest versions for additional vulnerabilities. The scrutiny is not just limited to Log4j; security researchers, and likely threat actors, are reportedly turning to other popular open-source products to test them for vulnerabilities.

    As the latest developments show, the full impact of the Log4j vulnerability has yet to be determined. Organizations, regardless of size and sector, need to remain on guard, vigilant in their remediation, and prepared for potential exploits within their own environments and throughout their supply chains.


    1 CISA has created an Apache Log4J Vulnerability Guidance webpage and is maintaining a community-sourced GitHub repository that provides a list of publicly available information and vendor-supplied advisories regarding the Log4j vulnerability.

    Authors

    Mark E. Schreiber

    Counsel

    Boston

    Robert Duffy

    Counsel

    Washington, DC

    More insights

  • Fifth Circuit Brings Enforcement Back Into the Mix: The Latest Court Moves with the CMS Vaccination Mandate

    Fifth Circuit Brings Enforcement Back Into the Mix: The Latest Court Moves with the CMS Vaccination Mandate

    ARTICLE / CLIENT ALERT

    Fifth Circuit Brings Enforcement Back Into the Mix: The Latest Court Moves with the CMS Vaccination Mandate

    December 16, 2021

    Read time: 9 min

    Key takeaways
    Overview

    This article was updated on December 29, 2021.

    A flurry of litigation in federal district and appellate courts has led to an even split between states in which the COVID-19 vaccine mandate issued by the Centers for Medicare and Medicaid Services may be implemented and states in which such implementation has been prevented. Additional appeals are expected shortly; however, the practical effect of these decisions on enforcement of CMS’ mandate remains uncertain.

    In depth

    Yesterday, two federal courts issued orders that, together, significantly impact the Biden administration’s authority to implement and enforce the COVID-19 vaccine mandate issued by the Centers for Medicare and Medicaid Services (CMS). The first order, issued by the US Court of Appeals for the Fifth Circuit, has the effect of allowing the federal government to proceed with its efforts to implement the COVID-19 vaccine mandate issued by CMS in more than two dozen states. The second order, issued by a federal court in Texas, bars the federal government from implementing the CMS vaccine mandate in the State of Texas. As we explain in more detail below, the combined effect of yesterday’s orders, as well as recent actions by other federal courts, is that the Biden administration is presently authorized to implement the CMS vaccine mandate in 25 states [1], but precluded from doing so in 25 states [2].

    More broadly, yesterday’s orders are the latest in a series of actions by federal courts across the country that reveal vastly different views of the outer limits of the Biden administration’s statutory and constitutional authority to compel vaccination in the healthcare sector, and the proper scope of a remedy appropriate to address allegations that the federal government exceeded such authority.

    Background

    As we noted here, on November 5, 2021, CMS issued an Interim Final Rule with comment (IFR) requiring certain persons employed or otherwise affiliated with 15 categories of healthcare facilities to receive the first of a two-dose COVID-19 vaccine, or a one-dose COVID-19 vaccine, or to request a federally recognized exemption by December 6, 2021, and to be fully vaccinated or receive an exemption no later than January 4, 2022. Additional administrative requirements, including confirming and storing evidence of staff vaccination and adopting policies and procedures, were also included in the IFR. The 30-day timeline for meeting the December 6 “Phase I” compliance date left many covered providers scrambling.

    On November 2, 2021, Florida filed a lawsuit challenging the IFR. Three other lawsuits challenging the IFR soon followed—one each in Missouri, Louisiana and Texas. Within three weeks, federal courts in Louisiana and Missouri granted the plaintiffs’ respective requests for a preliminary injunction, prohibiting the federal government from implementing or enforcing the IFR during the pendency of the litigation [3]. Importantly, the Louisiana court issued an order, styled as a “nationwide” injunction (Louisiana Order), prohibiting the federal government from implementing the IFR in all states except the 10 states that brought the Missouri lawsuit, as those states were granted relief under an order issued by the federal court in Missouri (Missouri Order). The combined effect of the Louisiana Order and the Missouri Order was to prohibit the federal government from implementing the IFR in all 50 states, because the Missouri Order prohibits the government from implementing the IFR in Missouri, Nebraska, Arkansas, Kansas, Iowa, Wyoming, Alaska, South Dakota, North Dakota and New Hampshire—the 10 states that are not covered by the Louisiana Order.

    The government immediately appealed both the Missouri Order and the Louisiana Order. In addition, hoping to get the vaccination train back on track, the government filed a motion before the district courts in Missouri and Louisiana, asking each court to “stay”—hold in abeyance—its order halting implementation of the IFR while the government pursued an appeal in each case. The district courts in Missouri and Louisiana promptly denied both requests. The government then filed a motion before the US Court of Appeals for the Fifth Circuit—the appellate court responsible for reviewing the Louisiana Order—seeking a “stay” of the Louisiana Order, as well as before the US Court of Appeals for the Eighth Circuit—the appellate court responsible for reviewing the Missouri Order—seeking a stay of the Missouri Order.

    On December 13, 2021, the US Court of Appeals for the Eighth Circuit issued an order denying the federal government’s request to halt the Missouri Order. The Eighth Circuit’s order—which the court of appeals issued without an accompanying opinion—effectively created a pathway for the federal government to salvage the IFR in the near term by petitioning the US Supreme Court to review the Missouri Order, which, as noted above, currently prohibits the federal government from implementing the IFR in ten states.

    On December 15, 2021—two days after the Eighth Circuit issued the order denying the government’s request to stay the Missouri Order—the US Court of Appeals for the Fifth Circuit issued an order granting in part and denying in part the government’s request to stay the Louisiana Order. The Fifth Circuit denied the government’s request to stay the Louisiana Order as it relates to the fourteen states that brought the Louisiana litigation—Louisiana, Montana, Arizona, Alabama, Georgia, Idaho, Indiana, Mississippi, Oklahoma, South Carolina, Utah, West Virginia, Kentucky and Ohio—but granted the government’s request as to all states that did not bring the Louisiana litigation. On December 15, 2021, a federal district court in Texas granted the plaintiffs’ motion for a preliminary injunction in the Texas litigation (Texas Order).

    The upshot of the orders issued yesterday by the Fifth Circuit and the federal district court in Texas is that the Biden administration may not implement the IFR in the states that brought the Louisiana lawsuit (Louisiana, Montana, Arizona, Alabama, Georgia, Idaho, Indiana, Mississippi, Oklahoma, South Carolina, Utah, West Virginia, Kentucky and Ohio) and the Missouri lawsuit (Missouri, Nebraska, Arkansas, Kansas, Iowa, Wyoming, Alaska, South Dakota, North Dakota and New Hampshire), as well as the State of Texas, but may implement the IFR in all other states and US territories.

    The Arguments

    In granting the plaintiffs’ requests to enjoin the Biden administration from implementing the IFR, the district courts in Missouri, Louisiana and Texas expressed concerns about the federal government’s statutory and constitutional authority to compel employees, contractors and other associated individuals in the healthcare sector to inoculate.

    First, the courts concluded that the plaintiffs were likely to succeed on the merits of their challenge to the IFR, because CMS failed to comply with the “notice-and-comment” procedure required by law under the Administrative Procedures Act. Specifically, the courts held that federal officials failed to follow this statutorily mandated procedure or demonstrate “good cause” as to why compliance was not required under the circumstances.

    Second, the courts held that the plaintiffs’ claims were likely to succeed, because Congress did not grant the Secretary of Health and Human Services (and, by delegation, CMS) the authority to issue the IFR. Although Congress authorized the Secretary of Health and Human Services to administer the Medicare and Medicaid programs, the courts opined, it did not expressly confer upon the Secretary the authority to issue the kind of broad, sweeping vaccination mandate set forth in the IFR.

    Third, the courts held that the IFR was “arbitrary and capricious” for several reasons, including, among other things, that the federal government failed to consider what two of the courts referred to as “obvious” alternatives to a vaccine requirement, such as periodic testing, or adequately take into account the impact the mandate would have on existing staff shortages in certain geographic areas.

    Finally, the Louisiana court highlighted a smorgasbord of constitutional concerns about the IFR, such as, for example, concerns that it violates the states’ police power, the Anti-Commandeering Doctrine and the Non-Delegation Doctrine.

    The Way Forward

    As noted above, the Missouri Order, the Louisiana Order and the Texas Order presently bar the federal government from implementing or enforcing the IFR in 25 states.

    In the meantime, the government may appeal the Texas Order and ask the district court to stay the Texas Order as it litigates the appeal. Should the federal district court in Texas deny a motion to stay the Texas Order, the Biden administration will continue to be prohibited from implementing the IFR in Texas, as well as the aforementioned 24 states subject to the Missouri Order and the Louisiana Order. On the other hand, if the federal district court in Texas grants a government motion to stay the Texas Order during the pendency of the government’s appeal, the Biden administration may implement the IFR in Texas.

    In a December 2, 2021, memo to State Agency Survey Directors (QSO-22-04-ALL) (the QSO Memo), CMS announced that it would suspend enforcement of the vaccination mandate, based upon the Missouri and Louisiana Orders. On December 28, 2021, CMS reversed its position on enforcement and announced that it plans to begin enforcing its vaccination rule in the 25 states where enforcement is not currently stayed. Enforcement will be phased, with the deadline for first vaccine doses now January 27, 2022; and the deadline for second vaccine doses now February 28, 2022. The Supreme Court will decide whether enforcement of the CMS and OSHA vaccine rules should be stayed sometime after oral argument set for January 7, 2022.

    Key Takeaways

    As activity among the various courts on the scope and applicability of the CMS mandate and injunctions against its enforcement continue, covered providers subject to the CMS mandate need to remain alert for developments and further guidance from CMS. See update on recent enforcement activity.

    Endnotes
    [1] These jurisdictions include, until further notice, California, Colorado, Connecticut, Delaware, Florida, Hawaii, Illinois, Maine, Maryland, the Commonwealth of Massachusetts, Michigan, Minnesota, Nevada, New Jersey, New Mexico, New York, North Carolina, Oregon, the Commonwealth of Pennsylvania, Rhode Island, Tennessee, Vermont, the Commonwealth of Virginia, Washington, and Wisconsin.

    [2] These jurisdictions include, until further notice, Alabama, Alaska, Arizona, Arkansas, Georgia, Idaho, Indiana, Iowa, Kansas, the Commonwealth of Kentucky, Louisiana, Mississippi, Missouri, Montana, Nebraska, New Hampshire, North Dakota, Ohio, Oklahoma, South Carolina, South Dakota, Texas, Utah, West Virginia, and Wyoming.

    [3] A federal court in Florida denied the plaintiff’s motion for a preliminary injunction, and subsequently the US Court of Appeals for the Eleventh Circuit upheld the district court’s order. As we discuss below, Texas moved for a preliminary injunction on November 16, 2021, and the district court granted the motion on December 15, 2021.

    Authors

    Sandra M. DiVarco

    Partner

    Chicago

    More insights

  • New York City COVID-19 Vaccine Mandate: Here Are the Details

    New York City COVID-19 Vaccine Mandate: Here Are the Details

    ARTICLE / CLIENT ALERT

    New York City COVID-19 Vaccine Mandate: Here Are the Details

    December 16, 2021

    Read time: 4 min

    Key takeaways
    Overview

    On December 13, 2021, New York City’s Commissioner of the New York City Department of Health and Mental Hygiene (DOHMH), Dr. Dave A. Chokshi, published an order (the Order) requiring private employers to impose COVID-19 vaccine mandates upon all in-person employees within New York City, with limited exceptions, as of December 27, 2021. DOHMH provided a series of FAQs and additional guidance on December 15, 2021. The Order follows Mayor Bill de Blasio’s December 6, 2021, announcement of this impending mandate.

    In depth

    Key points of the Order are as follows:

    BASIC REQUIREMENT

    Beginning December 27, 2021, covered employers must publicly post an affirmation of compliance with the Order’s requirements, and they must not permit any employees from entering their workplace unless the employee provides proof of having received at least one dose of a COVID-19 vaccine. Proof of the second dose must come within 45 days (i.e., by February 10, 2022).

    Limited exceptions to this requirement are described below. The Order is silent as to COVID-19 testing, as this would not satisfy the Order’s requirements.

    COVERED EMPLOYERS

    “Covered entities” are those responsible for ensuring their employees are vaccinated in accordance with the Order. This includes entities that employ more than one worker within New York City or who maintain a workplace in New York City. This also includes self-employed individuals.

    The Order extends to rideshare drivers as well as entities that operate coworking spaces which are responsible for ensuring proof of vaccination for individuals who rent a portion of the coworking space (though commercial landlords are not considered “covered entities” except with respect to their own employees).

    COVERED EMPLOYEES

    All employees who perform work within New York City, and who come into contact with at least one other individual as part of that work (e.g., colleagues, customers, patrons, visitors, etc.), are covered by the Order’s requirements.

    EXCEPTIONS

    The Order does not apply to:

    • Employees who enter the employer’s workplace for only a “quick and limited” purpose (e.g., using the bathroom, making a delivery or punching in and then promptly departing);
    • Remote employees, or those who may come to an in-person workplace but do not come in contact with any colleagues, customers, clients, visitors or others during their work;
    • Employees who are entitled to reasonable accommodations (DOHMH published guidance for employers on accommodating workers under the Order); and
    • Workers who are not residents of New York City and who are performing artists, college/university or professional athletes, or individuals accompanying these workers, who are not obligated to provide proof of vaccination under the current Key to NYC mandates.

    ENFORCEMENT AND PENALTIES

    The Order will be enforced by New York City inspectors from various New York City agencies. Fines begin at $1,000 for noncompliance. However, the FAQs emphasize that the goal is to work with businesses to be compliant and “avoid fines and penalties.”

    COORDINATION WITH STATE AND FEDERAL REQUIREMENTS

    New York State Commissioner of Health Mary T. Bassett issued a statewide mask-or-vaccine mandate, effective December 13, 2021, requiring masks to be worn in all indoor public spaces unless the business or venue has implemented a vaccination requirement. (FAQs on the statewide vaccination-or-mask mandate.) Given the New York City “universal” employment-based vaccination mandate, employers and employees in New York City will be required to follow the vaccination mandate without a masking alternative, subject to the exceptions described above. The state’s mask-or-vaccine mandate is scheduled to last until January 15, 2022, when its necessity will be reassessed.

    LOOKING AHEAD

    New York City Mayor-elect Eric Adams will be taking office on January 1, 2022, just five days after New York City begins to enforce this Order. Mayor-elect Adams has declined to comment publicly as to whether he plans to maintain this mandate once he assumes office. In the past, Mayor-elect Adams has publicly supported the state’s more moderate “vax-or-mask” requirement.

    Authors

    Abigail M. Kagan

    Partner

    New York – One Vanderbilt Avenue

    More insights

  • CFPB Updates Electronic Fund Transfers FAQs

    CFPB Updates Electronic Fund Transfers FAQs

    ARTICLE / CLIENT ALERT

    CFPB Updates Electronic Fund Transfers FAQs

    December 16, 2021

    Read time: 5 min

    Key takeaways
    Overview

    On Dec. 13, 2021, the Consumer Financial Protection Bureau (“CFPB”) updated its FAQs compliance aid[1] on electronic fund transfers (“EFTs”).[2] The prior June 4, 2021 version highlighted certain Regulation E requirements and noted Regulation E violations it had previously identified in its Supervisory Highlights, which included (1) requiring consumers to provide notice of error within a shorter time frame than required by law,[3] (2) requiring consumers to file a police report or other documentation to initiate an error resolution investigation,[4] and (3) requiring the consumer to contact the merchant about a potential unauthorized EFT before initiating an error resolution investigation.[5]

    The updated guidance emphasizes the CFPB’s expectations with respect to the interaction among the following provisions of the Electronic Fund Transfer Act (“EFTA”) and its implementing regulation, Regulation E:[6] (1) coverage of person-to-person (“P2P”) and mobile payment transactions, (2) the “service provider” provisions of Regulation E,[7] (3) error resolution procedures and consumer liability limits, and (4) unauthorized EFTs.

    None of the guidance appears to be a new interpretation of the EFTA or Regulation E. Rather, the FAQs appear to emphasize the broad consumer protections Regulation E affords consumers who hold asset accounts, including checking, savings, prepaid and mobile accounts, particularly within the framework of non-bank P2P providers who operate amidst a diversity of threats from cybercriminals.

    While the guidance does not establish new requirements under Regulation E, the FAQs — which consist of about twenty-four (24) sets of questions and answers — reiterate to industry certain requirements, including the following we highlight below:

    • Non-bank providers of EFT services may be covered “service providers” subject to certain requirements of Regulation E.[8] Generally, a person who provides EFT services to a consumer, but does not hold the consumer’s account may be a “service provider” under Regulation E if the person (1) issues an access device that the consumer can use to access the account, and (2) no agreement exists between the access device issuer and the account-holding financial institution. Importantly, whether a “service provider” is involved may impact the error resolution responsibilities of the account-holding institution.
    • Regulation E limits consumer liability for unauthorized EFTs conducted by fraudsters.[9] The CFPB affirms Regulation E protections for consumers where fraudsters first obtain account access information through hacking, phishing, tricking or fraudulently inducing the customer and then using such information to conduct unauthorized EFTs.
    • Multiple institutions involved in an unauthorized EFT may be subject to the error resolution requirements of Regulation E.[10] If an unauthorized EFT occurs, all covered financial institutions involved must comply with the error resolution requirements of Regulation E, and the consumer is protected by the liability protections for unauthorized EFTs under Regulation E. The FAQs focus on such scenarios in the context of P2P payment providers where unauthorized transfers involve both account-holding financial institutions and non-bank providers, both of whom may have responsibilities under the error resolution provisions of Regulation E.

    As a reminder, anyone in the payments space, including bank and non-bank providers must carefully consider their responsibilities and consumers’ rights and protections under Regulation E.

    Schulte Roth & Zabel’s lawyers are available to assist you in addressing any questions you may have regarding these developments. Please contact the Schulte Roth & Zabel lawyer with whom you usually work, or any of the following attorneys:

    Donald J. Mosher – New York (+1 212.756.2187, donald.mosher@srz.com)

    Kara A. Kuchar – New York (+1 212.756.2734, kara.kuchar@srz.com)

    Jessica Sklute – New York (+1 212.756.2180, jessica.sklute@srz.com)

    Melissa G.R. Goldstein – Washington, DC (+1 202.729.7471, melissa.goldstein@srz.com)

    Adam J. Barazani – New York (+1 212.756.2519, adam.barazani@srz.com)

    Jessica Romano – New York (+1 212.756.2205, jessica.romano@srz.com)

    Hadas A. Jacobi – New York (+1 212.756.2055, hadas.jacobi@srz.com)

    Steven T. Cummings – New York (+1 212.756.2251, steven.cummings@srz.com)


    [1] “Compliance Aids” are a relatively new category of compliance resources produced by the CFPB. Compliance Aids are not “rules” under the Administrative Procedures Act, and they are not intended to make decisions that bind regulated entities. Rather, “Compliance Aids are designed to accurately summarize and illustrate the underlying rules and statutes.” 85 Fed. Reg. 4579 (Jan. 27, 2020), available  here.

    [2] The updated FAQs can be found here.

    [3] FAQ 3 of Error Resolution.

    [4] FAQ 4 of Error Resolution.

    [5] FAQ 9 of Error Resolution: Unauthorized EFTs.

    [6] 15 U.S.C. § 1693, et seq.; 12 C.F.R. Part 1005.

    [7] 12 C.F.R. § 1005.14.

    [8] FAQs 1–4 of Coverage: Financial Institutions.

    [9] See, e.g., FAQs 3–6 of Error Resolution: Unauthorized EFTs.

    [10] FAQ 4 of Error Resolution: Unauthorized EFTs.


    This communication is issued by Schulte Roth & Zabel LLP for informational purposes only and does not constitute legal advice or establish an attorney-client relationship. In some jurisdictions, this publication may be considered attorney advertising. ©2021 Schulte Roth & Zabel LLP.

    All rights reserved. SCHULTE ROTH & ZABEL is the registered trademark of Schulte Roth & Zabel LLP.

    In depth
    Authors

    Donald J. Mosher

    Partner

    New York – 919 Third Avenue

    Melissa G.R. Goldstein

    Partner

    New York – 919 Third Avenue

    Adam J. Barazani

    Partner

    New York – 919 Third Avenue

    More insights

  • Private Client 2022 UK & Global Overview

    ARTICLE

    Private Client 2022 UK & Global Overview

    December 15, 2021

    Read time: 2 min

    Key takeaways
    Overview

    Simon Gibb, Abigail Nott, Sarah Gabbai and Justine Wadhera contributed to the chapter, United Kingdom – England & Wales in Lexology Getting The Deal Through, Private Client 2022, the team discuss how an individual’s place of domicile and residence are the principal factors in determining how they may be taxed in the UK.

    Jennifer Ronz, Anita Shah and Nicholas Holland also contributed to the Global Overview chapter in Lexology Getting The Deal Through, Private Client 2022. The editors discuss a time of overwhelming change and some of the investment trends in the private client arena.

    Reproduced with permission from Law Business Research Ltd. This article was first published in Lexology Getting The Deal Through – Private Client 2022. For further information, please visit http://www.lexology.com/gtdt.

    In depth
    Authors
    More insights